EMEA-000608-PIP01-09
Key facts
| Active substance |
Pagibaximab
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/212/2010
|
| PIP number |
EMEA-000608-PIP01-09
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Prevention of bacterial sepsis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Biosynexus, Incorporated
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|